SIRT1 and breast cancer: Additionally, upon selective pharmacological inhibition of SIRT1 in colon and breast cancer cell lines, we identify novel acetyl-lysine residues in endogenous MeCP2, at sites known to be relevant for DNA or protein-protein interaction.